Postmus PE - Search Results

1

Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer.

Kok K, Osinga J, Carritt B, Davis MB, van der Hout AH, van der Veen AY, Landsvater RM, de Leij LF, Berendsen HH, Postmus PE, et al. Kok K, et al. Among authors: postmus pe. Nature. 1987 Dec 10-16;330(6148):578-81. doi: 10.1038/330578a0. Nature. 1987. PMID: 2825033

2

A phase II study of high dose epirubicin in unresectable non small cell lung cancer.

Smit EF, Berendsen HH, Piers DA, Smeets J, Riva A, Postmus PE. Smit EF, et al. Among authors: postmus pe. Br J Cancer. 1992 Mar;65(3):405-8. doi: 10.1038/bjc.1992.82. Br J Cancer. 1992. PMID: 1313691 Free PMC article. Clinical Trial.

3

Second-line carboplatin-based chemotherapy for small cell lung cancer: the Groningen experience.

Postmus PE, Smit EF, Berendsen HH, Haaxma-Reiche H. Postmus PE, et al. Semin Oncol. 1992 Feb;19(1 Suppl 2):17-23. Semin Oncol. 1992. PMID: 1329219 Clinical Trial.

4

Treatment of brain metastases of small cell lung cancer with teniposide.

Postmus PE, Smit EF, Berendsen HH, Sleijfer DT, Haaxma-Reiche H. Postmus PE, et al. Semin Oncol. 1992 Apr;19(2 Suppl 6):89-94. Semin Oncol. 1992. PMID: 1329230

5

A feasibility study of testing new drugs for small-cell lung cancer in patients with a poor performance status.

Postmus PE, Smit EF, Berendsen HH, Sleyfer DT. Postmus PE, et al. Cancer Chemother Pharmacol. 1991;27(6):490-1. doi: 10.1007/BF00685167. Cancer Chemother Pharmacol. 1991. PMID: 1849466

6

High-dose etoposide for meningeal carcinomatosis in patients with small cell lung cancer.

Postmus PE, Haaxma-Reiche H, Berendsen HH, Sleijfer DT. Postmus PE, et al. Eur J Cancer Clin Oncol. 1989 Feb;25(2):377-8. doi: 10.1016/0277-5379(89)90033-3. Eur J Cancer Clin Oncol. 1989. PMID: 2539295 No abstract available.

7

Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features.

Berendsen HH, de Leij L, Poppema S, Postmus PE, Boes A, Sluiter HJ, The H. Berendsen HH, et al. Among authors: postmus pe. J Clin Oncol. 1989 Nov;7(11):1614-20. doi: 10.1200/JCO.1989.7.11.1614. J Clin Oncol. 1989. PMID: 2553880

8

A phase II study of carboplatin and vincristine in previously treated patients with small-cell lung cancer.

Smit EF, Berendsen HH, de Vries EG, Mulder NH, Postmus PE. Smit EF, et al. Among authors: postmus pe. Cancer Chemother Pharmacol. 1989;25(3):202-4. doi: 10.1007/BF00689583. Cancer Chemother Pharmacol. 1989. PMID: 2557171

9

Phase II evaluation of trans-N3P3Az2(NHMe)4 (AZP) in non-small cell lung cancer.

Postmus PE, Mulder NH, Grampel JC, Meyers WH, Berendsen HH. Postmus PE, et al. Eur J Cancer Clin Oncol. 1987 Aug;23(8):1207-8. doi: 10.1016/0277-5379(87)90156-8. Eur J Cancer Clin Oncol. 1987. PMID: 2820748

10

Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy.

Postmus PE, Berendsen HH, van Zandwijk N, Splinter TA, Burghouts JT, Bakker W. Postmus PE, et al. Eur J Cancer Clin Oncol. 1987 Sep;23(9):1409-11. doi: 10.1016/0277-5379(87)90128-3. Eur J Cancer Clin Oncol. 1987. PMID: 2824211

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

535 results

Search Page

Filters